AIDx – AI Diagnostics Excellence Cluster
| Reference number | |
| Coordinator | Region Uppsala - Klinisk mikrobiologi och vårdhygien Akademiska sjukhuset |
| Funding from Vinnova | SEK 1 500 000 |
| Project duration | October 2025 - March 2026 |
| Status | Ongoing |
| Venture | Cluster of Excellence for Cutting-Edge Technologies - calls for proposals |
| Call | Visions for world-leading research and innovation in strategic technology areas |
Important results from the project
The AIDx planning project identified and prioritised 12 AI use cases for clinical genomic diagnostics in Sweden, based on two national workshops with clinicians, bioinformaticians, AI researchers, industry representatives and patient organisations. Infrastructure assessment confirmed that the National Genomics Platform (NGP) meets technical and security requirements for AI applications. Regulatory and ethical prerequisites were mapped to the EU AI Act, GDPR, and IVDR.
Expected long term effects
The project provides the foundation for a national excellence cluster that can position Sweden as a European leader in AI-enabled precision diagnostics, with improved patient outcomes, shorter diagnostic turnaround times, and strengthened competitiveness for Swedish healthtech actors.
Approach and implementation
The project was implemented through a steering group comprising all nine project partners, two national workshops (use case identification and refinement), infrastructure assessment of the NGP, regulatory discussions, and knowledge exchange and dissemination through conferences and digital channels.